Total synthesis addresses stereochemical challenges in Norsecurinamine B, highlighting strategic design elements.
Norsecurinamine B represents the first example of an NH-bridged dimeric Securinega alkaloid, in which two norsecurinine monomers are joined through an amine linker at their endo faces. However, the exo face of norsecurinine is intrinsically favored for nucleophilic attack, rendering the synthesis of the target challenging. Herein, we disclose a convergent total synthesis of norsecurinamine B, highlighting the strategic design elements that effectively address this stereochemical challenge.
No takes yet. Share an insight, caveat, or question.
SHIN et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: